NeuroPace (NPCE) Capital Expenditures (2020 - 2026)
NeuroPace's (NPCE) quarterly Capital Expenditures came in at $117000.0 in Q1 2026, up 216.22% year-on-year from $37000.0 in Q1 2025, and up 20.62% quarter-over-quarter from $97000.0 in Q4 2025.
NeuroPace (NPCE) Capital Expenditures (2020 - 2026) Analysis & Trends
NeuroPace's Capital Expenditures history runs 7 years deep, the most recent figure standing at $117000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 216.22% year-over-year to $117000.0 in Q1 2026; TTM through Mar 2026 was $412000.0, a 41100.0% increase from a year earlier, with the FY2025 full-year figure at $332000.0, up 1647.37% from the prior year.
- Capital Expenditures advanced to $117000.0 in Q1 2026 per NPCE's latest filing, from $97000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $439000.0 in Q2 2022 and bottomed at -$248000.0 in Q4 2024.
- The 5-year median for Capital Expenditures is $76000.0 (2024), against an average of $77750.0.
- Biggest YoY gain for Capital Expenditures was 1011.11% in 2024; the steepest drop was 875.0% in 2024.
- Year by year, Capital Expenditures stood at $102000.0 in 2022, then tumbled by 68.63% to $32000.0 in 2023, then tumbled by 875.0% to -$248000.0 in 2024, then soared by 139.11% to $97000.0 in 2025, then grew by 20.62% to $117000.0 in 2026.
- Per Business Quant, the three latest NPCE Capital Expenditures figures stand at $117000.0 (Q1 2026), $97000.0 (Q4 2025), and $30000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | 117,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117,000.00 |
| Mar 31, 2026 | 117,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | -248,000.00 |
| Dec 31, 2024 | -248,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |